Further evidence that the CCK2 receptor is coupled to two transduction pathways using site-directed mutagenesis

Journal of Neurochemistry

Volumn 85, Issue 2, 2003, Pages 454-461

  Pommier, Blandine ^a   Marie Claire, Cynthia ^a   Da Nascimento, Sophie ^a   Wang, Hung Li ^b   Roques, Bernard P ^a   Noble, Florence ^a,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c INSERM   (France)

Author keywords

Arachidonic acid; CCK2 receptor; Cholecystokinin; G proteins; Inositol phosphate; Second messengers

Indexed keywords

ARACHIDONIC ACID; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL PHOSPHATE; LIGAND; MEPACRINE; PERTUSSIS TOXIN; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; RECEPTOR SUBTYPE; CHOLECYSTOKININ B RECEPTOR; ENZYME INHIBITOR; PHOSPHOLIPASE A; TRITIUM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; MUTANT; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR UPREGULATION; SECOND MESSENGER; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; WILD TYPE; AMINO ACID SUBSTITUTION; ANIMAL; BINDING COMPETITION; BIOSYNTHESIS; CELL STRAIN COS1; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHYSIOLOGY; RADIOASSAY;

ANIMALIA;

AMINO ACID SUBSTITUTION; ANIMALS; ARACHIDONIC ACID; BINDING, COMPETITIVE; COS CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; INOSITOL PHOSPHATES; LIGANDS; MUTAGENESIS, SITE-DIRECTED; PERTUSSIS TOXIN; PHOSPHOLIPASES A; RADIOLIGAND ASSAY; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; SIGNAL TRANSDUCTION; SINCALIDE; TRANSFECTION; TRITIUM;

EID: 0037390930     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01690.x     Document Type: Article

References (40)

1. Akagi K., Nagao T. and Urushidani T. (1997) Calcium oscillations in single cultured Chinese Hamster Ovary cells stably transfected with a cloned human cholecystokinin (CCK) B receptor. Jpn J. Pharmacol. 75, 33-42.
2. Bockaert J. and Pin J. P. (1999) Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 18, 1723-1729.
3. Coleman D. E., Berghuis A. M., Lee E., Linder M. E., Gilman A. G. and Sprang S. R. (1994) Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis. Science 265, 1405-1412.
4. 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc. Natl Acad. Sci. USA 87, 2896-2900.
5. Crawley J. N. and Corwin R. L. (1994) Biological actions of cholecystokinin. Peptides 15, 731-755.
6. Derrien M., McCort-Tranchepain I., Ducos B., Roques B. P. and Durieux C. (1994) Heterogeneity of CCK-B receptors involved in animal models of anxiety. Pharmacol. Biochem. Behav. 49, 133-141.
7. Durieux C., Coppey M., Zajac J. M. and Roques B. P. (1986) Occurrence of two cholecystokinin binding sites in guinea pig brain cortex. Biochem. Biophys. Res. Commun. 137, 1167-1173.
8. 3H]SNF 8702. Mol. Pharmacol. 41, 1089-1095.
9. q protein activation without affecting its association with the receptor. J. Biol. Chem. 275, 17 321-17 327.
10. Harper E. A., Roberts S. P., Shankley N. P. and Black J. W. (1996) Analysis of variation in L-365,260 competition curves in radioligand binding assays. Br. J. Pharmacol. 118, 1717-1726.
11. Higashijima T, Burnier J. and Ross E. M. (1990) Regulation of Gi and Go by mastoparan, related amphiphilic peptides, and hydrophobic amines. J. Biol. Chem. 265, 14 176-14 186.
12. Imamura F., Arimoto I., Fujiyoshi Y. and Doi T. (2000) W276 mutation in the endothelin receptor subtype impairs Gq coupling but not Gi or Go coupling. Biochemistry 39, 686-692.
13. 100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction. Mol. Pharmacol. 48, 783-789.
14. Jagerschmidt A., Guillaume N., Roques B. P. and Noble F. (1998) Binding sites and transduction process of the cholecystokinin B receptor: involvement of highly conserved aromatic residues of the transmembrane domains evidenced by site-directed mutagenesis. Mol. Pharmacol. 53, 878-885.
15. Kenakin T. (1995) Agonist-receptor efficacy II: agonist trafficking of receptor signals. Trends Pharmacol. Sci. 16, 232-238.
16. 26-33): evidence for CCK-B receptor heterogeneity. J. Pharmacol. Exp. Ther. 255, 1278-1286.
17. Kobilka B. (1992) Adrenergic receptors as models for G protein-coupled receptors. Annu. Rev. Neurosci. 15, 87-114.
18. Kopin A. S., McBride E. W., Schaffer K. and Beinborn M. (2000) CCK receptor polymorphisms: an illustration of emerging themes in pharmacogenomics. Trends Pharmacol. Sci. 21, 346-353.
19. Leff P., Scaramellini C., Law C. and McKechnie K. (1997) A three-state model of agonist action. Trends Pharmacol. Sci. 18, 355-362.
20. Lefkowitz R. J., Cotecchia S., Samama P. and Costa T. (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14, 303-307.
21. Lo W. W. Y. and Hughes J. (1988) Differential regulation of cholecystokinin- and muscarinic-receptor-mediated phosphoinositide turnover in flow 900 cells. Biochem. J. 251, 625-630.
22. Lodge D. J., Short J. L., Mercer L. D., Beart P. M. and Lawrence A. J. (2000) CCK/dopamine interactions in Fawn-Hooded and WistarKyoto rat brain. Peptides 21, 379-386.
23. Marino C. R., Leach S. D., Schaefer J. F., Miller L. J. and Gorelick F. S. (1993) Characterization of cAMP-dependent protein kinase activation by CCK in rat pancreas. FEBS Lett. 316, 48-52.
24. Moran T. H., Robinson P. H., Goldrich M. S. and McHugh P. R. (1986) Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res. 362, 175-179.
25. Noble F., Wank S., Crawley J., Bradwejn J., Seroogy K., Hamon M. and Roques B.P. (1999) International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol. Rev. 51, 745-781.
26. 2-adrenergic receptors based upon characteristics in primary structure. J. Biol. Chem. 267, 15 985-15 992.
27. Palczewski K., Kumasaka T., Hori T. et al. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739-745.
28. Pandol S. J., Hsu Y., Kondratenko N. F., Schoeffield-Payne M. S. and Steinbach J. H. (1991) Dual pathways for agonist-stimulated arachidonic acid release in pancreatic acini: roles in secretion. Am. J. Physiol. 260, G423-G433.
29. Perez D. M., Hwa J., Gaivin R., Mathur M., Brown F. and Graham R. M. (1996) Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. Mol. Pharmacol. 49, 112-122.
30. Pommier B., Da Nascimento S., Dumont S., Bellier B., Million A., Garbay C., Roques B. P. and Noble F. (1999) The cholecystokinin-B receptor is coupled to two effector pathways through pertussis toxin-sensitive and -insensitive G proteins. J. Neurochem. 73, 281-288.
31. Rodriguez M., Lignon M. F., Galas M. C., Amblard M. and Martinez J. (1990) Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors. Mol. Pharmacol. 38, 333-341.
32. Schwartz T. W. and Rosenkilde M. M. (1996) Is there a 'lock' for all agonist 'keys' in 7 TM receptors? Trends Pharmacol. Sci. 17, 213-216.
33. Strader C. D., Fong T. M., Tota M. R., Underwood D. and Dixon R. A. (1994) Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63, 101-132.
34. Sukumar M. and Higashijima T. (1992) G protein-bound conformation of mastoparan-X, a receptor-mimetic peptide. J. Biol. Chem. 267, 21 421-21 424.
35. q protein in pancreatic acini. Biochem. Biophys. Res. Commun. 211, 648-655.
36. Wang H. L. (1997) Basic amino acids at the C-terminus of the third intracellular loop are required for the activation of phospholipase C by cholecystokinin-B receptors. J. Neurochem. 68, 1728-1735.
37. Wank S. A. (1995) Cholecystokinin receptors. Am. J. Physiol. 269, G628-G646.
38. Wess J., Liu J., Blin N., Yun J., Lerche C. and Kostenis E. (1997) Structural basis of receptor/G protein coupling selectivity studied with muscarinic receptors as model systems. Life Sci. 60, 1007-1014.
39. Yule D. I., Tseng M. J., Williams J. A. and Logsdon C. D. (1993) A cloned CCK-A receptor transduces multiple signals in response to full and partial agonists. Am. J. Physiol. 265, G999-G1004.
40. Zhang L. J., Lu X. Y. and Han J. S. (1992) Influences of cholecystokinin octapeptide on phosphoinositide turnover in neonatal-rat brain cells. Biochem. J. 285, 847-850.